Participating Faculty

The American Journal of Managed Care

This supplement to includes information on best practices in diabetes management, including the effects of drug benefit design and quality of care measures in improving diabetes care.

Faculty

Lawrence Blonde, MD, FACP, FACEDirector

Ochsner Clinic Foundation

Corporate Medical Director

Stamford, Connecticut

Patrick J. O'Connor, MD, MPH

HealthPartners Research Foundation

Clinical Investigator

Minneapolis, Minnesota

Disclosure Statement

The American Journal of Managed Care

It is the policy of to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest.

The following participants have declared no financial affiliations with corporate organizations:

Patrick J. O'Connor, MD, MPH

JoAnn M. Sperl-Hillen, MD

These participants have declared the following affiliations with corporate organizations:

Lawrence Blonde, MD, FACP, FACE

Grant/Research Support From/Consultant For/Honoraria From:

• AstraZeneca
• BD
• Eli Lilly and Company
• GlaxoSmithKline
• Novartis Pharmaceuticals Corporation
• Pfizer

Sanofi-Aventis

Consultant For/Honoraria From:

• LifeScan

Merck/Schering-Plough

Honoraria From:

• Takeda Pharmaceuticals of America

Wyeth

John J. Mahoney, MD

Initial work on the predictive modeling discussed in his article was funded by a grant from Eli Lilly and Company.

The American Journal of Managed Care,

Signed disclosures are on file at the offices of Jamesburg, New Jersey.

This publication was made possible by funding from GlaxoSmithKline.

The contents of this supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

Download PDF: Participating Faculty